Korea’s First Home-Grown COVID-19 Vaccine To Speed Hub Ambitions

World-First Approval Expected Soon

 
• By Jung Won Shin

Only one last step remains before the approval of South Korea’s first home-grown COVID-19 vaccine as SK Bioscience’s SKYCovione (GBP510) receives positive assessments from review committees. Any nod, which could happen this week, would mark a milestone for the country's ambitions of becoming a global vaccine hub.

Kyung-Won Seo, Director General, National Institute of Food and Drug Safety Evaluation
One Last Hurdle For SK Bioscience’s SKYCovione Approval • Source: Korea's Ministry of Food and Drug Safety

More from South Korea

More from Asia